Amy Han is an accomplished leader in the oncology field with a strong background in commercialization and product development. Currently serving as Vice President of Global Commercialization for Solid Tumors at Genmab since January 2021, Amy has previously held significant positions at The Janssen Pharmaceutical Companies of Johnson & Johnson, including Commercial Disease Area Leader for Solid Tumor Targeted Therapies and Senior Director for Lung Cancer & New Business Development. Amy's early career included roles at Merck & Co., Genta, and Johnson & Johnson, where important contributions were made in oncology marketing and product management. Amy holds a Master of Science in Chemistry from Stony Brook University and a Bachelor of Science in Chemistry from Binghamton University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices